This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (16)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Randomized Study

Ronald L. Stephens, MD; Barth Hoogstraten, MD; Charles Haas, MD; Gary Clark, PhD

Arch Intern Med. 1978;138(1):115-117.

Abstract
A prospective randomized trial between two drug regimens in 38 patients with advanced pancreatic carcinoma was performed. The two-drug regimen consisted of carmustine and fluorouracil. The survival rate and response to these two drugs was compared to a three-drug regimen consisting of these same two drugs plus spironolactone. Objective partial responses were rare in both groups, being 3/18 in the two-drug group and 2/20 in the three-drug group. Life table analysis in previously untreated patients from time of treatment shows longer survival for the three-drug group, but this difference was not statistically significant.

(Arch Intern Med 138:115-117, 1978)

Author Affiliations
From the Division of Clinical Oncology (Drs Stephens, Hoogstraten, and Haas), Department of Medicine, and the Department of Biometry (Dr Clark), University of Kansas Medical Center, Kansas City.

Footnotes
Accepted for publication March 4, 1977.

Reprint requests to Division of Clinical Oncology, 3rd Floor Student Center, University of Kansas Medical Center, 39th and Rainbow Blvd, Kansas City, KS 66103 (Dr Stephens).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?